Posted by Michael Wonder on 19 Jul 2024
More than 40,000 people could benefit after NICE recommends new ‘take at home’ pill for advanced prostate cancer
19 July 2024 - A new pill to treat advanced hormone sensitive prostate cancer that could benefit just over 40,000 people has been recommended by NICE in final draft guidance.
Relugolix, also known as Orgovyx and made by Accord, is the first oral treatment of its kind to be approved by NICE.
